Index of reports
> Cases with Renal Failure Acute (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vinblastine where reactions include renal failure acute. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Vinblastine side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-11
Patient: 28 year old female
Reactions: Streptococcal Bacteraemia, Vomiting, Nausea, Peripheral Sensorimotor Neuropathy, Carbon Monoxide Diffusing Capacity Decreased, Pancytopenia, Febrile Neutropenia, Hypoaesthesia, Paraesthesia, Gait Disturbance, Coordination Abnormal, Renal Failure Acute
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cisplatin
Dosage: 45 mg/m2, unk
Bleomycin Sulfate
Dosage: 15 units/m2 over 24h on day2
Etoposide
Dosage: 200 mg/m2, over 2h on day3
Indication: Ovarian Cancer
Cyclophosphamide
Dosage: 750 mg/m2, unk
Cisplatin
Dosage: 90 mg/m2, over 4h on day1
Indication: Ovarian Cancer
Doxorubicin HCL
Dosage: 30 mg/m2, unk
Etoposide
Dosage: 100 mg/m2, unk
Cyclophosphamide
Dosage: 1000 mg/m2, over 60min on day 2
Indication: Ovarian Cancer
Doxorubicin HCL
Dosage: 45 mg/m2, over 30min on day3
Indication: Ovarian Cancer
Vinblastine
Dosage: 6 mg/m2, over 30 minutes on day 1
Indication: Ovarian Cancer
Other drugs received by patient: Pegfilgrastim
Possible Vinblastine side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: 28 year old female
Reactions: Streptococcal Bacteraemia, Vomiting, Nausea, Peripheral Sensorimotor Neuropathy, Carbon Monoxide Diffusing Capacity Decreased, Pancytopenia, Febrile Neutropenia, Hypoaesthesia, Paraesthesia, Coordination Abnormal, Gait Disturbance, Renal Failure Acute
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cisplatin
Dosage: 90 mg/m2 over 4h on day1
Indication: Ovarian Cancer
Cisplatin
Dosage: 45 mg/m 2
Etoposide
Dosage: 200 mg/m2 over 2h on day3
Indication: Ovarian Cancer
Cyclophosphamide
Dosage: 1000 mg/m2 over 60min on day 2
Indication: Ovarian Cancer
Bleomycin
Dosage: 15 units/m2 over 24h on day2
Doxorubicin HCL
Dosage: 45 mg/m2 over 30min on day3
Indication: Ovarian Cancer
Etoposide
Dosage: 100 mg/m 2
Cyclophosphamide
Dosage: 750 mg/m 2
Doxorubicin HCL
Dosage: 30 mg/m 2
Vinblastine
Dosage: 6mg/m2 over 30min on day1
Indication: Ovarian Cancer
Other drugs received by patient: Pegfilgrastim
Possible Vinblastine side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-04
Patient: 28 year old female
Reactions: Streptococcal Bacteraemia, Vomiting, Nausea, Carbon Monoxide Diffusing Capacity Decreased, Febrile Neutropenia, Pancytopenia, Neuropathy Peripheral, Bacteraemia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Indication: Ovarian Cancer
Vinblastine Sulfate
Vinblastine Sulfate
Cisplatin
Etoposide
Vinblastine Sulfate
Cisplatin
Cyclophosphamide
Indication: Ovarian Cancer
Cyclophosphamide
Bleomycin Sulfate
Etoposide
Indication: Ovarian Cancer
Etoposide
Doxorubicin HCL
Dosage: cycle 5
Indication: Ovarian Cancer
Doxorubicin HCL
Dosage: cycle 3
Vinblastine
Indication: Ovarian Cancer
Vinblastine Sulfate
Bleomycin Sulfate
Doxorubicin HCL
Dosage: cycle 6
Cisplatin
Etoposide
Etoposide
Cisplatin
Cisplatin
Cyclophosphamide
Etoposide
Doxorubicin HCL
Dosage: cycle 1
Vinblastine Sulfate
Cyclophosphamide
Cyclophosphamide
Doxorubicin HCL
Dosage: cycle 2
Doxorubicin HCL
Dosage: cycle 4
Cyclophosphamide
Bleomycin Sulfate
Indication: Ovarian Cancer
Bleomycin Sulfate
Other drugs received by patient: Pegfilgrastim; Pegfilgrastim; Pegfilgrastim; Pegfilgrastim; Pegfilgrastim; Pegfilgrastim
|